Results from the company’s Phase I/II trial showed the injectable therapy to have an effective half-life of 91.4 hours.
Female astronauts drive personalized space medicine, closing knowledge gaps to benefit space travelers and people on Earth.
Life Molecular Imaging (LMI) and St. Teresa's Hospital are pleased to announce that Florbetaben (18F) Injection (brand name: Neuraceq®) will be available in Hong Kong from St. Teresa's Hospital by ...
An eight-day mission has turned into a nine-month space stint for two NASA astronauts who are finally set to come home. But ...
Artificial intelligence (AI) is providing several tools in revolutionising treatment options in neuro-oncology, especially in ...
New genomic techniques can increase food security and mitigate climate change effects. EU rules aim to regulate these plant ...
Prostate cancer remains one of the most commonly diagnosed cancersworldwide, with 1.4 million new cases and over 375,000 ...
Beloved DC cherry tree ‘Stumpy’ was chopped down thanks to climate change. But the ‘folk hero’ lives on - The online famous ...
"Our goal is to make it a bit easier for them." Company unveils game-changing tech that can protect food supply amid ...
Smith-Bindman and like-minded colleagues have long pushed for federal policies aimed at improving safety for patients ...
At 35, Katie Dutton is already a rectal cancer survivor, an ordeal that started with seemingly benign symptoms doctors ...